Stone, Trevor W.

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology

Tryptophan and brain disordersNeuroscience and Neuropharmacology Research

Cited by 751

Obesity and cancer: existing and new hypotheses for a causal connection

Stone, T. W., McPherson, M., & Gail Darlington, L. (2018) · eBioMedicine

Cancer Risks and FactorsAdipokines, Inflammation, and Metabolic Diseases

Cited by 262

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology

Circadian rhythm and melatoninNeuroscience and Neuropharmacology Research

Cited by 225

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders

Huang, Y.-S., Ogbechi, J., Clanchy, F. I., Williams, R. O., & Stone, T. W. (2020) · Frontiers in Immunology

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 187

Kynurenic acid antagonists and kynurenine pathway inhibitors

Stone, T. W. (2001) · Expert Opinion on Investigational Drugs

Tryptophan and brain disordersAmino Acid Enzymes and Metabolism

Cited by 79

Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation

Khalil, O. S., Forrest, C. M., Pisar, M., Smith, R. A., Darlington, L. G., & Stone, T. W. (2013) · Immunopharmacology and Immunotoxicology

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 14